The Peer Review Process: Past, Present, and Future.


Journal

British journal of biomedical science
ISSN: 2474-0896
Titre abrégé: Br J Biomed Sci
Pays: Switzerland
ID NLM: 9309208

Informations de publication

Date de publication:
2024
Historique:
received: 15 09 2023
accepted: 29 05 2024
medline: 2 7 2024
pubmed: 2 7 2024
entrez: 2 7 2024
Statut: epublish

Résumé

The peer review process is a fundamental aspect of modern scientific paper publishing, underpinning essential quality control. First conceptualised in the 1700s, it is an iterative process that aims to elevate scientific literature to the highest standards whilst preventing publication of scientifically unsound, potentially misleading, and even plagiarised information. It is widely accepted that the peer review of scientific papers is an irreplaceable and fundamental aspect of the research process. However, the rapid growth of research and technology has led to a huge increase in the number of publications. This has led to increased pressure on the peer review system. There are several established peer review methodologies, ranging from single and double blind to open and transparent review, but their implementation across journals and research fields varies greatly. Some journals are testing entirely novel approaches (such as collaborative reviews), whilst others are piloting changes to established methods. Given the unprecedented growth in publication numbers, and the ensuing burden on journals, editors, and reviewers, it is imperative to improve the quality and efficiency of the peer review process. Herein we evaluate the peer review process, from its historical origins to current practice and future directions.

Identifiants

pubmed: 38952614
doi: 10.3389/bjbs.2024.12054
pii: 12054
pmc: PMC11215012
doi:

Types de publication

Journal Article Review Historical Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12054

Informations de copyright

Copyright © 2024 Drozdz and Ladomery.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

John A Drozdz (JA)

Department of Applied Sciences, University of the West of England, Bristol, United Kingdom.

Michael R Ladomery (MR)

Department of Applied Sciences, University of the West of England, Bristol, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH